Metraipolis › archive › dc_9bfc2f2941e8

Nanomedicine Meets Immunotherapy: Transforming Chimeric Antigen Receptor T Cell Treatment for Solid Tumors — Europe PMC PMID:41737839

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41737839
DOI
10.1002/smsc.202500596
License (as archived)
solo-consultazione
Archived
2026-11-06T04:23:21.299Z
SHA-256 of the archived text
3b9da5c8f96b81d8a123ff16b6edde5de9102a8ffcfff30d267c9340ec4a02fd
Stable URL of this page
https://metraipolis.com/documento/dc_9bfc2f2941e8

How to cite

Nanomedicine Meets Immunotherapy: Transforming Chimeric Antigen Receptor T Cell Treatment for Solid Tumors — Europe PMC PMID:41737839 — Europe PMC (en), https://europepmc.org/article/MED/41737839 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9bfc2f2941e8 (Metraipolis archive dc_9bfc2f2941e8, sha256 3b9da5c8f96b81d8a123ff16b6edde5de9102a8ffcfff30d267c9340ec4a02fd)
BibTeX
@misc{dc9bfc2f2941e8,
  title = {Nanomedicine Meets Immunotherapy: Transforming Chimeric Antigen Receptor T Cell Treatment for Solid Tumors — Europe PMC PMID:41737839},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41737839},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9bfc2f2941e8; sha256 3b9da5c8f96b81d8a123ff16b6edde5de9102a8ffcfff30d267c9340ec4a02fd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41737839. Agents can read the archived copy with the MCP tool read_document.